Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Scandella

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Blood|May 15, 1997
The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study GroupsR Prescott, H Nakai, E L Saenko, et al.
The Journal of Biological Chemistry|October 16, 1999
Role of factor VIII C2 domain in factor VIII binding to factor XaK Nogami, M Shima, K Hosokawa, et al.
Blood|September 1, 1995
Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding siteD Scandella, G E Gilbert, M Shima, et al.
British Journal of Haematology|October 16, 1999
Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effectK Nogami, M Shima, H Nakai, et al.
Blood|March 26, 1999
Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia AK Peerlinck, M G Jacquemin, J Arnout, et al.
Thrombosis and Haemostasis|October 6, 2000
An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequenceM Shibata, M Shima, S Morichika, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Blood|May 15, 1997
The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study GroupsR Prescott, H Nakai, E L Saenko, et al.
The Journal of Biological Chemistry|October 16, 1999
Role of factor VIII C2 domain in factor VIII binding to factor XaK Nogami, M Shima, K Hosokawa, et al.
Blood|September 1, 1995
Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding siteD Scandella, G E Gilbert, M Shima, et al.
British Journal of Haematology|October 16, 1999
Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effectK Nogami, M Shima, H Nakai, et al.
Blood|March 26, 1999
Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia AK Peerlinck, M G Jacquemin, J Arnout, et al.
Thrombosis and Haemostasis|October 6, 2000
An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequenceM Shibata, M Shima, S Morichika, et al.
Pageof 5